![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, May 18, 2018 5:36:03 PM
Possible we could see the 100 if the phase trial on M254 hits it out of the box.
First, as I understand it, the drug is an already approved drug. We have hypersyalated the drug and it has shown to be 10 times more powerful in animal models. That is why i suspect this is going to be a short trial. If it shows it is 10 times more powerful as in animal studies, and no side effects. BOOM. Just figure out the proper dosing amounts. If they can also show subque at the same time it is over the top.
CW said it is our sleeper program. A 4 to 6 billion market and the cost savings if they can take it to a subque shot would blow the expenses on treatment and patient suffering and lost time on patient treatments out of the park. Patients could tx at home with subdue shots. The expense saving are beyond anything we can believe if it works.
Not long to find out now. CW said, as best I can remember, they have almost reached agreement on the trail which starts the second half.
Boing X 2
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM